200 related articles for article (PubMed ID: 12885661)
1. Molecular dynamics simulation of dimeric and monomeric forms of human prion protein: insight into dynamics and properties.
Sekijima M; Motono C; Yamasaki S; Kaneko K; Akiyama Y
Biophys J; 2003 Aug; 85(2):1176-85. PubMed ID: 12885661
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the effect of glycosylation on human prion protein by molecular dynamics.
Zhong L; Xie J
J Biomol Struct Dyn; 2009 Apr; 26(5):525-33. PubMed ID: 19236103
[TBL] [Abstract][Full Text] [Related]
3. Simulations of biomolecules: Characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine and human forms of the prion protein.
Alonso DO; An C; Daggett V
Philos Trans A Math Phys Eng Sci; 2002 Jun; 360(1795):1165-78. PubMed ID: 12804272
[TBL] [Abstract][Full Text] [Related]
4. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
5. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
6. Structural features of prions explored by sequence analysis. II. A PrP(Sc) model.
Mornon JP; Prat K; Dupuis F; Boisset N; Callebaut I
Cell Mol Life Sci; 2002 Dec; 59(12):2144-54. PubMed ID: 12568340
[TBL] [Abstract][Full Text] [Related]
7. Effects of pH and aggregation in the human prion conversion into scrapie form: a study using molecular dynamics with excited normal modes.
Lima AN; de Oliveira RJ; Braz ASK; de Souza Costa MG; Perahia D; Scott LPB
Eur Biophys J; 2018 Jul; 47(5):583-590. PubMed ID: 29546436
[TBL] [Abstract][Full Text] [Related]
8. Dynamic simulation of the mouse prion protein.
Guilbert C; Ricard F; Smith JC
Biopolymers; 2000 Nov; 54(6):406-15. PubMed ID: 10951327
[TBL] [Abstract][Full Text] [Related]
9. Mapping the early steps in the pH-induced conformational conversion of the prion protein.
Alonso DO; DeArmond SJ; Cohen FE; Daggett V
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):2985-9. PubMed ID: 11248018
[TBL] [Abstract][Full Text] [Related]
10. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
[TBL] [Abstract][Full Text] [Related]
11. Modeling a prion protein dimer: predictions for fibril formation.
Warwicker J
Biochem Biophys Res Commun; 2000 Nov; 278(3):646-52. PubMed ID: 11095963
[TBL] [Abstract][Full Text] [Related]
12. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
13. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
Dima RI; Thirumalai D
Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
[TBL] [Abstract][Full Text] [Related]
14. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
[TBL] [Abstract][Full Text] [Related]
15. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous conformational change within the prion protein--implications for disease pathogenesis?
Jackson GS
Bioessays; 2001 Sep; 23(9):772-4. PubMed ID: 11536289
[TBL] [Abstract][Full Text] [Related]
17. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
18. Self-assembly of recombinant prion protein of 106 residues.
Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
[TBL] [Abstract][Full Text] [Related]
19. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
[TBL] [Abstract][Full Text] [Related]
20. Scrapie prions: a three-dimensional model of an infectious fragment.
Huang Z; Prusiner SB; Cohen FE
Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
